Clinical Trials

NCT02182830 | COMPLETED | PHASE3

166 participants

24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2014-07-25

Completion:

2017-05-18

Conditions

• Diabetes Mellitus, Type 2
• Hypertension

Interventions

• DRUG

Results Available

NCT02164864 | COMPLETED | PHASE3

2725 participants

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2014-07-22

Completion:

2017-06-05

Conditions

• Atrial Fibrillation
• Percutaneous Coronary Intervention

Interventions

• DRUG

Results Available

NCT02164331 | COMPLETED | NA

76 participants

Blood Pressure (BP) Visit Intensification Study

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2013-10-31

Completion:

2017-12-31

Conditions

• Blood Pressure
• Hypertension

Interventions

• BEHAVIORAL

No Results Yet

NCT02152930 | TERMINATED | PHASE3

8 participants

The Effects of Fish Oil Supplements During Supervised Exercise Therapy in Patients With Intermittent Claudication

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2014-12-31

Completion:

2016-02-29

Conditions

• Intermittent Claudication

Interventions

• DRUG

No Results Yet

NCT02100514 | COMPLETED | PHASE3

746 participants

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2014-10-28

Completion:

2016-07-15

Conditions

• Hyperlipidemia

Interventions

• DRUG
• OTHER

Results Available

NCT01968967 | COMPLETED | PHASE3

2139 participants

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2013-10-29

Completion:

2016-07-05

Conditions

• Hyperlipidemia

Interventions

• DRUG
• OTHER

Results Available

NCT01963234 | COMPLETED | NA

439 participants

Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2014-03-31

Completion:

2017-06-30

Conditions

• Substance Use Disorders
• HIV

Interventions

• BEHAVIORAL

Results Available

NCT01962142 | COMPLETED

20 participants

Assessment of Activity Limitation in Asthma Patients

Study Type:

OBSERVATIONAL

Last Updated:

2018-07-31

Start Date:

2012-09-30

Completion:

2017-12-31

Conditions

• Asthma

Interventions

• OTHER

No Results Yet

NCT01880593 | COMPLETED | PHASE2

34 participants

Ketamine Plus Lithium in Treatment-Resistant Depression

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2013-07-31

Completion:

2016-11-30

Conditions

• Depression

Interventions

• DRUG

Results Available

NCT01867177 | COMPLETED | NA

583 participants

Community-based Interventions to Increase HIV Testing and HIV Care Utilization

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2013-06-30

Completion:

2016-12-31

Conditions

• HIV

Interventions

• OTHER
• BEHAVIORAL

No Results Yet

NCT01825941 | COMPLETED | PHASE4

208 participants

Diphenhydramine for Acute Migraine

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2013-04-30

Completion:

2014-12-31

Conditions

• Migraine

Interventions

• DRUG

Results Available

NCT01818583 | COMPLETED | PHASE4

143 participants

Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2013-03-31

Completion:

2017-11-30

Conditions

• Atrial Fibrillation
• Atrial Flutter

Interventions

• DRUG

No Results Yet

NCT01767155 | COMPLETED | PHASE3

511 participants

Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2013-04-30

Completion:

2017-01-30

Conditions

• Endometrial Cancer

Interventions

• DRUG

Results Available

NCT01765127 | COMPLETED

122 participants

An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)

Study Type:

OBSERVATIONAL

Last Updated:

2018-07-31

Start Date:

2012-01-31

Completion:

2017-02-28

Conditions

• Bipolar I Disorder

No Results Yet

NCT01734278 | COMPLETED

1000 participants

Observational Post-Authorisation Safety Study of Asenapine (Sycrest)

Study Type:

OBSERVATIONAL

Last Updated:

2018-07-31

Start Date:

2012-10-31

Completion:

2017-01-31

Conditions

• Manic Disorder

Interventions

• OTHER

No Results Yet

NCT01712347 | COMPLETED

351 participants

An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2018-07-31

Start Date:

2012-10-11

Completion:

2016-07-01

Conditions

• Colorectal Cancer

Interventions

• DRUG

No Results Yet

NCT01706185 | COMPLETED

156 participants

Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2018-07-31

Start Date:

2008-01-15

Completion:

2008-01-15

Conditions

• Neoplasms, Urinary Bladder

Interventions

• OTHER

No Results Yet

NCT01656304 | COMPLETED | PHASE2

16 participants

Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2007-05-31

Completion:

2012-01-31

Conditions

• Adenocarcinoma of the Prostate
• Recurrent Prostate Cancer
• Stage I Prostate Cancer
• Stage IIA Prostate Cancer
• Stage IIB Prostate Cancer
• Stage III Prostate Cancer

Interventions

• BIOLOGICAL
• OTHER

Results Available

NCT01639534 | COMPLETED

10 participants

Biomarkers of Ischemia: Xanthine, Hypoxanthine and Inosine Levels During Carotid Stenting Procedures

Study Type:

OBSERVATIONAL

Last Updated:

2018-07-31

Start Date:

2011-03-31

Completion:

2013-10-09

Conditions

• Identify the Presence of a Marker of Ischemia/Hypoperfusion of the Brain Via Peripheral Blood
• Ischemia/Hypoperfusion of Brain

No Results Yet

NCT01627340 | COMPLETED | PHASE4

667 participants

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2012-07-24

Completion:

2013-12-18

Conditions

• Hepatitis B

Interventions

• BIOLOGICAL

Results Available

NCT01587274 | COMPLETED | PHASE4

323 participants

A Randomized Study of Three Medication Regimens for Acute Low Back Pain

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2012-04-30

Completion:

2014-10-31

Conditions

• Acute Low Back Pain

Interventions

• DRUG

Results Available

NCT01575275 | TERMINATED | PHASE2

8 participants

Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2012-05-31

Completion:

2014-05-31

Conditions

• Adult Giant Cell Glioblastoma
• Adult Glioblastoma
• Adult Gliosarcoma
• Recurrent Adult Brain Tumor

Interventions

• DRUG
• PROCEDURE

Results Available

NCT01500278 | COMPLETED | PHASE4

915 participants

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2011-12-31

Completion:

2015-11-30

Conditions

• Rheumatoid Arthritis

Interventions

• BIOLOGICAL
• DRUG

Results Available

NCT01482962 | COMPLETED | PHASE3

271 participants

Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2012-06-11

Completion:

2015-06-30

Conditions

• Relapsed Peripheral T-Cell Lymphoma
• Refractory Peripheral T-Cell Lymphoma

Interventions

• DRUG

Results Available

NCT01460511 | COMPLETED | PHASE3

70 participants

Evaluation of Efficacy and Safety of E004 in Children With Asthma

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2011-10-31

Completion:

2012-03-31

Conditions

• Asthma

Interventions

• DRUG

No Results Yet

NCT01375946 | COMPLETED | PHASE1

24 participants

Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2011-05-31

Completion:

2011-06-30

Conditions

• Healthy

Interventions

• DRUG

Results Available

NCT01350674 | SUSPENDED | NA

50 participants

Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2010-12-31

Completion:

2017-12-31

Conditions

• Tuberculosis

Interventions

• PROCEDURE

No Results Yet

NCT01315691 | WITHDRAWN | PHASE3

0 participants

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Conditions

• Cystic Fibrosis

Interventions

• DRUG

No Results Yet

NCT01266031 | COMPLETED | PHASE1/PHASE2

96 participants

Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2011-07-12

Completion:

2015-06-30

Conditions

• Malignant Glioma
• Recurrent Glioblastoma

Interventions

• DRUG

Results Available

NCT01255761 | COMPLETED | PHASE4

736 participants

A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2010-11-30

Completion:

2012-10-31

Conditions

• Rheumatoid Arthritis

Interventions

• BIOLOGICAL

Results Available

NCT01194674 | TERMINATED | PHASE1/PHASE2

2 participants

Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2011-01-31

Completion:

2011-12-31

Conditions

• Uveitis

Interventions

• DRUG

Results Available

NCT01182675 | TERMINATED | PHASE2

7 participants

Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2010-08-31

Completion:

2013-09-30

Conditions

• Severe Combined Immunodeficiency

Interventions

• DRUG

Results Available

NCT01159847 | COMPLETED | PHASE1/PHASE2

30 participants

Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2010-01-31

Completion:

2012-07-31

Conditions

• Type 1 Diabetes

Interventions

• DRUG

No Results Yet

NCT01019252 | COMPLETED | NA

66 participants

Skills Training for Adolescents With ADHD

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2009-10-31

Completion:

2012-08-31

Conditions

• Attention Deficit Hyperactivity Disorder

Interventions

• BEHAVIORAL

Results Available

NCT00772889 | COMPLETED | PHASE3

971 participants

Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2008-10-09

Completion:

2009-12-15

Conditions

• Influenza

Interventions

• BIOLOGICAL

Results Available

NCT00765076 | COMPLETED | PHASE3

192 participants

Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2008-10-16

Completion:

2009-12-04

Conditions

• Influenza

Interventions

• BIOLOGICAL

Results Available

NCT00764790 | COMPLETED | PHASE3

3317 participants

Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2008-10-01

Completion:

2009-03-05

Conditions

• Influenza

Interventions

• BIOLOGICAL

Results Available

NCT00695669 | COMPLETED | PHASE2

312 participants

A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2008-06-05

Completion:

2008-08-13

Conditions

• Influenza

Interventions

• BIOLOGICAL

Results Available

NCT00626574 | TERMINATED | PHASE4

3 participants

Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2007-07-31

Completion:

2009-02-28

Conditions

• Subarachnoid Hemorrhage

Interventions

• DRUG

Results Available

NCT00577109 | WITHDRAWN | PHASE2

0 participants

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.

Study Type:

INTERVENTIONAL

Last Updated:

2018-07-31

Start Date:

2007-12-31

Completion:

2012-06-30

Conditions

• Colorectal Cancer

Interventions

• DRUG

No Results Yet